No Detail Found!

Formulation and evaluation of mucoadhesive dosage form containing Rosiglitazone Maleate.

Author(s)
Shiva S. Krishna Department of Pharmaceutics, Krupanidhi College of Pharmacy, #5 Sarjapur Road, Koramangala, Bangalore, India
Subhabrata Ray Department of Pharmaceutics, Krupanidhi College of Pharmacy, #5 Sarjapur Road, Koramangala, Bangalore, India
R. S. Thakur Department of Pharmaceutics, Krupanidhi College of Pharmacy, #5 Sarjapur Road, Koramangala, Bangalore, India
Abstract
Extending the residence time of a dosage form at a particular site and controlling the release of drug from the dosage form are useful especially for achieving controlled plasma level of the drug as well as improving bioavailability. The objective of this study was to extend the GI residence time of the dosage form and control the release of rosiglitazone using mucoadhesive tablet to achieve controlled plasma level of the drug which is especially useful after 8 to 12 weeks of monotherapy using conventional dosage forms when dose is doubled and plasma level also doubles. Direct compression method using simplex lattice design, followed by optimization of the evaluation parameters was employed to get final optimized formulation. The optimized formulation showed a mucoadhesive strength >40 gm-f, and a mucoadhesive time >12 hours with release profile closer to the target release profile and followed Non-Fickian diffusion mediated release of rosiglitazone maleate.
Publication Details
Page(s) 208-213
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 19, Issue: 3, Year: 2006

Request the full text from PASTIC

0

Citations

0

Downloads

125

Views